文献速递围术期管理与 ERAS急腹症与外科感染

疫情初期围术期获得性COVID-19感染风险:回顾性队列研究

Risk of Acquiring Perioperative COVID-19 During the Initial Pandemic Peak: A Retrospective Cohort Study.
PubMed 文献 · Ann Surg · 2021-01-01

该回顾性队列研究纳入2020年3月15日至5月15日期间在本院接受手术的501例术前COVID-19阴性成人患者,评估围术期获得性症状性COVID-19感染风险。9例(1.8%)术后出现症状性感染,全部发生于常规术前检测实施前;围术期感染与糖尿病、心血管疾病、ARB使用、移植手术及不良术后结局相关。

要点

  • 术前阴性患者围术期获得性症状性COVID-19感染率为1.8%。
  • 常规术前检测实施后感染风险显著降低(3.7% vs 0%,OR 0.048)。
  • 围术期感染与糖尿病、心血管病、ARB使用及移植手术相关。

核心结论

  • 疫情初期围术期获得性症状性COVID-19感染风险较低,尤其在实施常规术前检测后。
  • 围术期COVID-19感染与较差的术后结局相关。

研究设计与样本

  • 回顾性队列研究,纳入2020年3月15日至5月15日在本院接受手术的501例术前COVID-19阴性成人患者。

主要发现

  • 501例术前阴性患者中9例(1.8%)术后2-14天内出现症状性COVID-19。
  • 9例感染全部发生于常规术前检测实施前(9/243,3.7% vs 0/258,0%,OR 0.048,P=0.036)。
  • 手术当日PCR阴性者(n=170)无术后感染。
  • 围术期感染与术前糖尿病(OR 3.70,P=0.042)、心血管疾病(OR 3.69,P=0.043)、ARB使用(OR 6.58,P=0.004)、移植手术(OR 11.00,P=0.002)相关。
  • 围术期感染与多种并发症、再入院(OR 5.50,P=0.029)及死亡(OR 12.81,P=0.001)相关。

临床怎么用

  • 常规术前COVID-19检测可降低围术期获得性感染风险。
  • 对合并糖尿病、心血管疾病、使用ARB或接受移植手术的患者应加强围术期防护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the risk of acquiring perioperative COVID-19 infection in previously COVID-19 negative patients. SUMMARY OF BACKGROUND DATA: During the initial peak of the COVID-19 pandemic, there was significant concern of hospital acquired COVID-19 infections. Medical centers rapidly implemented systems to minimize perioperative transmission, including routine preoperative testing, patient isolation, and enhanced cleaning. METHODS: In this retrospective cohort study, medical records of all adult patients who underwent surgery at our quaternary, acute care hospital between March 15 and May 15, 2020 were reviewed. The risk of preoperatively negative patients developing symptomatic COVID-19 within 2-14 days postoperatively was determined. Surgical characteristics, outcomes, and complications were compared between those with and without acquired perioperative COVID-19 infection. RESULTS: Among 501 negative patients undergoing index surgeries, 9 (1.8%) developed symptomatic COVID-19 in the postoperative period; all occurred before implementation of routine preoperative testing [9/243, 3.7% vs 0/258, 0%, odds ratio (OR): 0.048, P = 0.036]. No patient who was polymerase-chain-reaction negative on the day of surgery (n = 170) developed postoperative infection. Perioperative infection was associated with preoperative diabetes (OR: 3.70, P = 0.042), cardiovascular disease (OR: 3.69, P = 0.043), angiotensin receptor blocker use (OR: 6.58, P = 0.004), and transplant surgery (OR: 11.00, P = 0.002), and multiple complications, readmission (OR: 5.50, P = 0.029) and death (OR: 12.81, P = 0.001). CONCLUSIONS: During the initial peak of the COVID-19 pandemic, there was minimal risk of acquiring symptomatic perioperative COVID-19 infection, especially after the implementation of routine preoperative testing. However, perioperative COVID-19 infection was associated with poor postoperative outcome.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Axiotakis LG, Youngerman BE, Casals RK, et al. Risk of Acquiring Perioperative COVID-19 During the Initial Pandemic Peak: A Retrospective Cohort Study. Ann Surg. 2021. PMID: 33156061. doi:10.1097/SLA.0000000000004586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。